Ga-68 PSMA-11 improves outcomes in prostate cancer patients

PET with a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA)-11 radiotrace...Read more on AuntMinnie.comRelated Reading: Lantheus gets FDA nod for Pylarify PET agent for prostate cancer Hoag launches PET trials for prostate cancer, myeloma Novel radiotracer shows promise for prostate imaging FDA makes history with approval of Ga-68 PSMA-11 PET Point Biopharma to use Lantheus' PyL in clinical trial
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news